간전이 치료 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 연평균 8.5%의 CAGR로 23억 7,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 환자 중심 치료 모델, 정밀 의료, 외래 및 외래 진료로의 전환, 규제 이니셔티브에 기인하는 것으로 추정됩니다. 예측 기간의 주요 동향으로는 차세대 시퀀싱 기술, 면역종양학의 발전, 액체 생검 기술의 등장, 보조요법 등이 있습니다.
간 질환의 유병률 증가는 당분간 간전이 치료 시장의 성장을 견인할 것으로 예상됩니다. 간 질환은 간 기능을 손상시키는 다양한 장애를 포함하며, 대사 및 해독과 같은 신체 기능 및 건강 전반에 위험을 초래합니다. 간전이 치료는 간 기능과 전신 건강을 유지하는 데 중요한 역할을 합니다. 장기적인 관해를 얻기 위해서는 외과적 절제, 절제술 또는 표적 치료를 포함한 종합적인 치료가 필요하며, 종종 화학요법이나 면역요법과 같은 전신 약물 요법으로 보완되는 경우가 많습니다. 예를 들어, Cancer Australia는 2022년 호주에서 새로 진단될 간암 환자가 약 2,905명에 달할 것으로 예상하고 있으며, 85세까지 간암에 걸릴 위험은 85세 이전에 간암이 발병할 것으로 예측하고 있어 간 질환에 효과적으로 대처하는 것이 중요함을 강조하고 있습니다. 간질환에 효과적으로 대처하는 것의 중요성이 강조되고 있습니다. 이처럼 간 질환의 유병률 증가는 간전이 치료 시장의 주요 촉진요인으로 작용하고 있습니다.
간전이 치료 시장의 주요 기업들은 효과적이고 편리한 치료 옵션을 제공하기 위해 간 지향성 치료의 도입에 주력하고 있습니다. 간 지향성 치료는 특히 간 관련 질환 및 병태를 표적으로 하여 간 내 암세포를 직접 표적으로 하여 간 전이 관리를 돕습니다. 이러한 치료법에는 외과적 절제술, 고주파열 소작술, 경동맥 화학색전술, 고주파열 색전술, 정위적 방사선 요법 등 다양한 접근법이 있습니다. 예를 들어, 델카스시스템즈는 2023년 8월 간 50% 미만의 간을 침범한 전이성 포도막 흑색종 성인 환자를 대상으로 하는 간 지향성 치료제인 헤파토(Hepzato) 키트를 출시하였습니다. 이 키트는 화학요법제인 멜파란을 델카스의 간 전달 시스템을 통해 간으로 직접 투여하여 전신 독성을 최소화하면서 표적 치료를 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 간전이 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 간전이 치료 시장 : 성장률 분석
- 세계의 간전이 치료 시장 실적 : 규모와 성장, 2019-2024
- 세계의 간전이 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 간전이 치료 전체 시장(TAM)
제6장 시장 세분화
- 세계의 간전이 치료 시장 : 치료 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 화학요법
- 표적요법
- 면역요법
- 세계의 간전이 치료 시장 : 원발성 암별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 대장암
- 유방암
- 세계의 간전이 치료 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 전문 약국
- 세계의 간전이 치료 시장, 화학요법 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세포 상해성 화학요법
- 수술 전 화학요법
- 보조 화학요법
- 세계의 간전이 치료 시장, 표적요법 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 티로신 키나아제 억제제(TKI)
- 단클론항체
- MTOR 억제제
- 세계의 간전이 치료 시장, 면역요법 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 면역관문억제제
- 암 백신
- 양자 세포 이식 요법
제7장 지역별·국가별 분석
- 세계의 간전이 치료 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 간전이 치료 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 간전이 치료 시장 : 경쟁 구도
- 간전이 치료 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Bayer AG
- Sanofi S.A.
- Novartis AG
- Bristol Myers Squibb
- AstraZeneca plc
- Eli Lilly and Company
- Amgen Inc.
- Boehringer Ingelheim
- Gilead Sciences Inc.
- Takeda Pharmaceutical Company
- Astellas Pharma Inc.
- Daiichi Sankyo Company Ltd.
- Eisai Co. Ltd.
- Incyte Corporation
- Ipsen
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 간전이 치료 시장 2029 : 새로운 기회를 제공하는 국가
- 간전이 치료 시장 2029 : 새로운 기회를 제공하는 부문
- 간전이 치료 시장 2029 : 성장 전략
제36장 부록
ksm
Liver metastases treatment involves therapeutic interventions targeted at managing cancerous growths that have spread to the liver from primary tumors elsewhere in the body. This comprehensive treatment strategy aims to improve patient outcomes by shrinking or eliminating metastatic lesions, alleviating symptoms, and enhancing overall quality of life.
The main types of liver metastases treatment include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy is a cancer treatment approach that utilizes drugs to destroy cancer cells. It is employed for treating liver metastasis resulting from various primary cancers such as colorectal cancer and breast cancer. Chemotherapy drugs are distributed through various channels including hospital pharmacies and specialty pharmacies.
The liver metastasis treatment market research report is one of a series of new reports from The Business Research Company that provides liver metastasis treatment market statistics, including liver metastasis treatment industry global market size, regional shares, competitors with a liver metastasis treatment market share, detailed liver metastasis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the liver metastasis treatment industry. This liver metastasis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The liver metastases treatment market size has grown strongly in recent years. It will grow from $1.57 billion in 2024 to $1.71 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to expansion of personalized medicine, expanded access to healthcare, enhanced multidisciplinary care, clinical trials and research initiatives.
The liver metastases treatment market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to patient-centric care models, precision medicine, shift towards outpatient, ambulatory care and regulatory initiatives. Major trends in the forecast period include next-generation sequencing technologies, immuno-oncology advancements, emergence of liquid biopsy technologies and adjuvant therapies.
The increasing incidence of liver disease is anticipated to drive the expansion of the liver metastases treatment market in the foreseeable future. Liver disease encompasses various disorders that impair the liver's function, posing risks to overall health and bodily functions such as metabolism and detoxification. Treatments for liver metastases play a critical role in preserving liver function and overall wellness. In many cases, comprehensive treatments involving surgical resection, ablation techniques, or targeted therapies are necessary for achieving long-term remission, often complemented by systemic medications such as chemotherapy or immunotherapy. For example, Cancer Australia reported approximately 2,905 new cases of liver cancer diagnosed in Australia in 2022, indicating a significant burden of the disease. The predicted risk of developing liver cancer by age 85 underscores the importance of addressing liver disease effectively. Thus, the increasing prevalence of liver disease acts as a key driver for the liver metastases treatment market.
Leading companies in the liver metastases treatment market are focused on introducing liver-directed therapies to provide effective and convenient treatment options. Liver-directed therapies specifically target liver-related diseases or conditions, aiding in the management of liver metastases by directly targeting cancerous cells within the liver. These therapies encompass various approaches, including surgical resection, radiofrequency ablation, transarterial chemoembolization, radioembolization, and stereotactic body radiation therapy. For instance, Delcath Systems Incorporated launched the Hepzato kit in August 2023, a liver-directed treatment for adult patients with metastatic uveal melanoma affecting less than 50% of the liver. The kit delivers melphalan, a chemotherapeutic agent, directly to the liver through Delcath's Hepatic Delivery System, offering targeted treatment while minimizing systemic toxicity.
In August 2023, TriSalus Life Sciences completed its merger with MedTech Acquisition Corporation, underscoring its commitment to advancing innovative treatments for liver and pancreatic tumors. TriSalus Life Sciences specializes in developing proprietary delivery technologies that enable precise and targeted delivery of immunotherapy agents directly to tumor sites, maximizing therapeutic efficacy while minimizing systemic side effects. The merger with MedTech Acquisition Corporation, a blank check company, signifies a strategic move aimed at accelerating the development and commercialization of novel treatments for liver and pancreatic tumors.
Major companies operating in the liver metastases treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol Myers Squibb, AstraZeneca plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim, Gilead Sciences Inc., Takeda Pharmaceutical Company, Astellas Pharma Inc., Daiichi Sankyo Company Ltd., Eisai Co. Ltd., Incyte Corporation, Ipsen, Seattle Genetics, Exelixis Inc., Array BioPharma Inc., Genentech Inc., Clovis Oncology, Agios Pharmaceuticals Inc., Taiho Pharmaceutical Co.Ltd
North America was the largest region in the liver metastases treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver metastases treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the liver metastases treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The liver metastases treatment market consists of revenues earned by entities by providing services such as surgery, radiotherapy, palliative care, diagnostic imaging, biopsy, ablation therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The liver metastases treatment market also includes sales of therasphere, sir-spheres gamma-90 resin microspheres, Avastin, Nexavar, Keytruda, radiofrequency ablation devices, and cyberknife. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Liver Metastases Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on liver metastases treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for liver metastases treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The liver metastases treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Treatment Type: Chemotherapy; Targeted Therapy; Immunotherapy
- 2) By Primary Cancer: Colorectal Cancer; Breast Cancer
- 3) By Distribution Channel: Hospital Pharmacies; Specialty Pharmacies
- Subsegments:
- 1) By Chemotherapy: Cytotoxic Chemotherapy; Neoadjuvant Chemotherapy; Adjuvant Chemotherapy
- 2) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs); Monoclonal Antibodies; MTOR Inhibitors
- 3) By Immunotherapy: Immune Checkpoint Inhibitors; Cancer Vaccines; Adoptive Cell Transfer Therapy
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co.; AbbVie Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Liver Metastases Treatment Market Characteristics
3. Liver Metastases Treatment Market Trends And Strategies
4. Liver Metastases Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Liver Metastases Treatment Growth Analysis And Strategic Analysis Framework
- 5.1. Global Liver Metastases Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Liver Metastases Treatment Market Growth Rate Analysis
- 5.4. Global Liver Metastases Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Liver Metastases Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Liver Metastases Treatment Total Addressable Market (TAM)
6. Liver Metastases Treatment Market Segmentation
- 6.1. Global Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- 6.2. Global Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Colorectal Cancer
- Breast Cancer
- 6.3. Global Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Specialty Pharmacies
- 6.4. Global Liver Metastases Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cytotoxic Chemotherapy
- Neoadjuvant Chemotherapy
- Adjuvant Chemotherapy
- 6.5. Global Liver Metastases Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tyrosine Kinase Inhibitors (TKIs)
- Monoclonal Antibodies
- MTOR Inhibitors
- 6.6. Global Liver Metastases Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Immune Checkpoint Inhibitors
- Cancer Vaccines
- Adoptive Cell Transfer Therapy
7. Liver Metastases Treatment Market Regional And Country Analysis
- 7.1. Global Liver Metastases Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Liver Metastases Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Liver Metastases Treatment Market
- 8.1. Asia-Pacific Liver Metastases Treatment Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Liver Metastases Treatment Market
- 9.1. China Liver Metastases Treatment Market Overview
- 9.2. China Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Liver Metastases Treatment Market
- 10.1. India Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Liver Metastases Treatment Market
- 11.1. Japan Liver Metastases Treatment Market Overview
- 11.2. Japan Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Liver Metastases Treatment Market
- 12.1. Australia Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Liver Metastases Treatment Market
- 13.1. Indonesia Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Liver Metastases Treatment Market
- 14.1. South Korea Liver Metastases Treatment Market Overview
- 14.2. South Korea Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Liver Metastases Treatment Market
- 15.1. Western Europe Liver Metastases Treatment Market Overview
- 15.2. Western Europe Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Liver Metastases Treatment Market
- 16.1. UK Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Liver Metastases Treatment Market
- 17.1. Germany Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Liver Metastases Treatment Market
- 18.1. France Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Liver Metastases Treatment Market
- 19.1. Italy Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Liver Metastases Treatment Market
- 20.1. Spain Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Liver Metastases Treatment Market
- 21.1. Eastern Europe Liver Metastases Treatment Market Overview
- 21.2. Eastern Europe Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Liver Metastases Treatment Market
- 22.1. Russia Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Liver Metastases Treatment Market
- 23.1. North America Liver Metastases Treatment Market Overview
- 23.2. North America Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Liver Metastases Treatment Market
- 24.1. USA Liver Metastases Treatment Market Overview
- 24.2. USA Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Liver Metastases Treatment Market
- 25.1. Canada Liver Metastases Treatment Market Overview
- 25.2. Canada Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Liver Metastases Treatment Market
- 26.1. South America Liver Metastases Treatment Market Overview
- 26.2. South America Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Liver Metastases Treatment Market
- 27.1. Brazil Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Liver Metastases Treatment Market
- 28.1. Middle East Liver Metastases Treatment Market Overview
- 28.2. Middle East Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Liver Metastases Treatment Market
- 29.1. Africa Liver Metastases Treatment Market Overview
- 29.2. Africa Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Liver Metastases Treatment Market Competitive Landscape And Company Profiles
- 30.1. Liver Metastases Treatment Market Competitive Landscape
- 30.2. Liver Metastases Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Liver Metastases Treatment Market Other Major And Innovative Companies
- 31.1. Bayer AG
- 31.2. Sanofi S.A.
- 31.3. Novartis AG
- 31.4. Bristol Myers Squibb
- 31.5. AstraZeneca plc
- 31.6. Eli Lilly and Company
- 31.7. Amgen Inc.
- 31.8. Boehringer Ingelheim
- 31.9. Gilead Sciences Inc.
- 31.10. Takeda Pharmaceutical Company
- 31.11. Astellas Pharma Inc.
- 31.12. Daiichi Sankyo Company Ltd.
- 31.13. Eisai Co. Ltd.
- 31.14. Incyte Corporation
- 31.15. Ipsen
32. Global Liver Metastases Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Liver Metastases Treatment Market
34. Recent Developments In The Liver Metastases Treatment Market
35. Liver Metastases Treatment Market High Potential Countries, Segments and Strategies
- 35.1 Liver Metastases Treatment Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Liver Metastases Treatment Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Liver Metastases Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
